Our study demonstrating that PRMT5 depletion in an established tumour can reduce stem cell frequency is highly significant for the patient, as targeting this enzyme in conjunction with standard chemotherapies, could lead to eradication of all tumours cells, thus preventing relapse.
← all excerpts
Linking PRMT5 to breast cancer stem cells: New therapeutic opportunities?
1
—
—